Mato AR, Tang B, Azmi S, Yang K, Zhang X, Stern JC, Hedrick E, Huang J, Sharman JP. A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib. Haematologica 2022;107(11):2630-2640; https://doi.org/10.3324/haematol.2021.280376.